XLXingchen Li

Xingchen Li

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Xingchen Li has a total of 27 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Non‐Invasive Assessment of Complete Regression in Endometrial Cancer Patients Undergoing Fertility Preservation Using MRI‐Based Radiomics and Immune Heterogeneity

    by Xingchen Li, Kun Shang, Jingyuan Wang, Aoxuan Zhu, Yuman Wu, Yue Qi, Xinyi Bi, Yiqin Wang, Jianliu Wang

    Fertility‐preserving treatment (FPT) offers a critical option for young women diagnosed with atypical endometrial hyperplasia (AEH) or early‐stage endometrial cancer (EC), however, the commonly used methods for evaluating complete regression (CR) are invasive. This study aimed to develop a non‐invasive tool to predict treatment outcomes using radiomics and molecular profiling. We retrospectively analyzed 146 patients with AEH or early EC receiving FPT. Radiomic features extracted from MRI were used to construct a radiomics signature predictive of CR through a machine‐learning approach. A radiomics‐clinical nomogram integrating radiomics scores with clinical variables demonstrated excellent predictive performance, with area under the curve values of 0.963 and 0.986 in the training and validation cohorts, respectively. Patients stratified into high‐ and low‐score groups based on radiomics scores showed significantly different CR rates, with the high‐score group exhibiting a lower likelihood of CR. Single‐cell RNA sequencing further confirmed immune alterations in the high‐score group, including reduced CD8 + T‐cells, and elevated levels of M2 macrophages. Bulk RNA sequencing revealed upregulation of oxidative phosphorylation and lipid metabolism pathways, suggesting a metabolically active and immunosuppressive tumor microenvironment. This radiomics‐based approach holds promise for guiding individualized FPT strategies for AEH and early EC patients.


  • Open Access

    Lipid‐Driven OLR1/FOXM1/FGF19 Axis Orchestrates Crosstalk in an Epithelial‐Fibroblast Positive Feedback Promoting Progesterone Resistance in Endometrial Cancer

    by Xingchen Li, Yue Qi, Yuman Wu, Xinyi Bi, Yiqin Wang, Jiaqi Wang, Jingyuan Wang, Lingpu Zhang, Haihua Xiao, Jianliu Wang

    Progesterone resistance (ProR) remains a major obstacle in the conservative management of endometrial cancer (EC). Here, a metabolic‐stromal signaling loop centered on the OLR1/FOXM1/FGF19 axis is identified that drives progesterone resistance in EC. Single‐cell transcriptomic profiling first revealed a striking correlation between epithelial cells and fibroblasts in EC tissues with ProR. Tumor epithelial cells display profound alterations in lipid metabolism, whereas fibroblasts exhibited enhanced oxidative stress signatures. Clinical samples analyses indicated that oxidized low density lipoprotein (oxLDL), a product of LDL oxidation, is associated with adverse outcomes. The binding of oxLDL to its receptor OLR1 promoted the expression of FOXM1, a transcription factor that directly upregulates fibroblast growth factor 19 (FGF19). Immunofluorescence confirmed not only the spatial co‐localization of epithelial cells and fibroblasts but also the enrichment of OLR1 within epithelial compartments. Furthermore, treatment with the antioxidant resveratrol (RSV) and its nanoformulation (RSV‐NPs) markedly inhibited tumor growth in mice with lipid metabolic disorders, highlighting their potential to counteract progesterone resistance by disrupting this OLR1/FOXM1/FGF19 axis. This work highlights the therapeutic potential of targeting the tumor–stroma metabolic axis to increase progesterone sensitivity and improve outcomes in EC patients with fertility‐preserving demands.


  • Open Access

    Diagnostic significance and predictive efficiency of metabolic risk score for fertility-sparing treatment in patients with atypical endometrial hyperplasia and early endometrial carcinoma

    by Xingchen Li, Yiqin Wang, Jiaqi Wang, Jingyi Zhou, Jianliu Wang

    Li X, et al. J Gynecol Oncol. 2024 Jan;35:e42. https://doi.org/10.3802/jgo.2024.35.e42


  • Open Access

    Development and validation of a prognostic model based on metabolic risk score to predict overall survival of endometrial cancer in Chinese patients

    by Xingchen Li, Xiao Yang, Yuan Cheng, Yangyang Dong, Jingyuan Wang, Jianliu Wang

    Li X, et al. J Gynecol Oncol. 2023 Jun;34:e69. https://doi.org/10.3802/jgo.2023.34.e69


  • Open Access

    Identification of an immune-related risk signature and nomogram predicting the overall survival in patients with endometrial cancer

    by Yuan Cheng, Xingchen Li, Yibo Dai, Yangyang Dong, Xiao Yang, Jianliu Wang

    Cheng Y, et al. J Gynecol Oncol. 2021 Jan;32(3):e30. https://doi.org/10.3802/jgo.2021.32.e30


  • Open Access

    Establishment and validation of a prognostic nomogram based on a novel five‐DNA methylation signature for survival in endometrial cancer patients

    by Xingchen Li, Fufen Yin, Yuan Fan, Yuan Cheng, Yangyang Dong, Jingyi Zhou, Zhiqi Wang, Xiaoping Li, Jianliu Wang

    Background: This study aimed to explore the prognostic role of DNA methylation pattern in endometrial cancer (EC) patients.Methods: Differentially methylated genes (DMGs) of EC patients with distinct survival from The Cancer Genome Atlas (TCGA) database were analyzed to identify methylated genes as biomarkers for EC prognosis. The Least Absolute Shrinkage and Selection Operator (LASSO) analysis was used to construct a risk score model. A nomogram was built based on analysis combining the risk score model with clinicopathological signatures together, and then verified in the validation cohort and patients in our own center.Results: In total, 157 DMGs were identified between different prognostic groups. Based on the LASSO analysis, five genes (GBP4, OR8K3, GABRA2, RIPPLY2, and TRBV5‐7) were screened for the establishment of risk score model. The model outperformed in prognostic accuracy at varying follow‐up times (AUC for 3 years: 0.824, 5 years: 0.926, and 7 years: 0.853). Multivariate analysis identified four independent risk factors including menopausal status (HR = 3.006, 95%CI: 1.062–8.511, p = 0.038), recurrence (HR = 2.116, 95%CI: 1.061–4.379, p = 0.046), lymph node metastasis (LNM, HR = 3.465, 95%CI: 1.225–9.807, p = 0.019), and five‐DNA methylation risk model (HR = 3.654, 95%CI: 1.458–9.161, p = 0.006) in training cohort. The performance of the nomogram was good in the training (AUC = 0.828), validation (AUC = 0.866) and the whole cohorts (AUC = 0.843). Furthermore, we verified the nomogram with 24 patients in our center and the Kaplan–Meier survival curve also proved to be significantly different (p < 0.01). The subgroup analysis in different stratifications indicated that the accuracy was high in different subgroups for age, histological type, tumor grade, and clinical stage (all p < 0.01).Conclusions: Briefly, our work established and verified a five‐DNA methylation risk model, and a nomogram merging the model with clinicopathological characteristics to facilitate individual prediction of EC patients for clinicians.


  • Open Access

    Ankle joint pressure change in varus malalignment of the tibia

    by Yuan Zhu, Xingchen Li, Xiangyang Xu

    Background: Varus malalignment of the tibia could alter ankle biomechanics, and might lead to degenerative changes of the ankle joint. However, previous studies failed to report the detailed changes of ankle biomechanics in varus malalignment of the tibia. The aim of this biomechanical study was to evaluate how the ankle joint pressure would change in response to the incremental increases in varus malalignment of the tibia. Methods: Eight fresh-frozen human cadaver legs were tested in this study. Varus malalignment of the tibia and a total of 600 N compressive force was simulated using a custom made fixture. Intra-articular sensors (TeckScan) were inserted in the ankle joint to collect the ankle joint pressure data. The testing sequence was 0°, 2°,4°,6°,8°,10°,12°,14°,16°,18°,20° of tibial varus. Results: As the tibial varus progressed, the center of force (COF) shifted laterally both for the medial and lateral aspect of the ankle joint. For the medial aspect of the ankle joint, the lateral shift reached its maximum at 8° [2.76 (1.62) mm, p = 0.002] of tibial varus, while for the lateral aspect of the ankle joint, the lateral shift reached its maximum at 12° [2.11 (1.19) mm, p = 0.002] of tibial varus. Thereafter, the COF shifted medially as the tibial varus progressed. For the lateral aspect of the ankle joint, The Pmean increased from 2103.8 (625.1) kPa at 0° to 2295.3 (589.7) kPa at 8° of tibial varus (p = 0.047), significant difference was found between the Pmean at 0° and 8° (p = 0.047) of tibial varus. Then as the tibial varus progressed, the Pmean decreased to 1748.9 (467.2) kPa at 20° of tibial varus (p = 0.002). The lateral joint pressure ratio also increased from 0.481 (0.125) at 0° to 0.548 (0.108) at 10° of tibial varus (p = 0.002), then decreased to 0.517 (0.101) at 20° of tibial varus (p = 0.002) . Conclusions: For mild tibial varus deformities, there was a lateral shift of COF and lateral stress concentration within the ankle joint. However, as the tibial varus progressed, the COF shifted medially and the lateral stress concentration decreased.